31.62
Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten
Is LENZ Therapeutics Inc. a growth stock or a value stockBreakneck growth rates - jammulinksnews.com
How strong is LENZ Therapeutics Inc. company’s balance sheetTriple-digit wealth increases - jammulinksnews.com
Has LENZ Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewFree AI-Powered Stock Predictions - Newser
How Efficient Is LENZ Therapeutics Inc. at Controlling Operating CostsHigh Reward Risk Balanced Trading - Newser
How LENZ Therapeutics Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser
What makes LENZ Therapeutics Inc. stock price move sharplyInsider Strategy Insight - Metal.it
What analysts say about LENZ Therapeutics Inc. stockMarket-leading growth rates - PrintWeekIndia
LENZ Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital appreciation - Autocar Professional
Analysts Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) Target Price at $46.60 - Defense World
All Eyes On LENZWill The Regulatory Catalyst Ignite A Rally Or Sink The Stock? - RTTNews
Is LENZ Therapeutics Inc. a good long term investmentFree Stock Market Beginners Guide - jammulinksnews.com
What drives LENZ Therapeutics Inc. stock priceConsistently high yield - jammulinksnews.com
LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
what makes lenz therapeutics inc. stock price move sharplyVolume Spike Monitors - Newser
Why LENZ Therapeutics Inc. stock attracts strong analyst attentionReliable High Profit Alerts - Newser
Does LENZ Therapeutics, Inc. (LENZ) Have the Potential to Rally 30.86% as Wall Street Analysts Expect? - Yahoo Finance
Versant funds sell $6.5 million in Lenz Therapeutics (LENZ) - Investing.com Australia
Versant funds sell $6.5 million in Lenz Therapeutics (LENZ) By Investing.com - Investing.com Canada
Leerink Partnrs Has Bearish Outlook for LENZ FY2028 Earnings - Defense World
William Blair Maintains LENZ Therapeutics(LENZ.US) With Buy Rating - 富途牛牛
LENZ Therapeutics Shares Soar 4.93% on Strategic Partnership, Regulatory Milestone - AInvest
LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada - VisionMonday.com
LENZ and Théa partner on Canadian commercialization of presbyopia eye drop - Eyes On Eyecare
LENZ Therapeutics and Laboratoires Théa partner to commercialize LNZ100 for presbyopia in Canada - Ophthalmology Times
Lenz Therapeutics stock gains as William Blair reiterates Outperform By Investing.com - Investing.com Nigeria
Lenz Therapeutics stock gains as William Blair reiterates Outperform - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):